Efficacy and safety of GW117 tablets in major depressive disorder: a randomised, double-blind, placebo-controlled, phase 2 dose-finding study
{{output}}
Background: GW117 (N-(2-(6-chloro-7-deuteromethoxy-naphthalen-1-yl) ethyl) acetamide) is a dual-acting agent (MT1/MT2 agonist, 5-HT2C antagonist) with prior evidence of antidepressant efficacy and favourable safety. ... ...
